Accessibility settings

This paper is in the following e-collection/theme issue:

Genomics and Bioinformatics for Clinical Use (116) Clinical Informatics (2256) Clinical Information and Decision Making (3691) Machine Learning (3163) Artificial Intelligence (4750)

Published on in Vol 14 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/84636, first published .
Young man in a yellow beanie receiving IV treatment in a clinic.

Integrated Clinical-Molecular Risk Stratification in Diffuse Large B-Cell Lymphoma: Machine Learning Survival Analysis

Integrated Clinical-Molecular Risk Stratification in Diffuse Large B-Cell Lymphoma: Machine Learning Survival Analysis

Authors of this article:

Jin Zhao1, 2 Author Orcid Image ;   Xiaolian Wen1, 2 Author Orcid Image ;   Li Ma1, 2 Author Orcid Image ;   Liping Su1, 2 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Jin Zhao   1, 2 * , MSc ;   Xiaolian Wen   1, 2 * , MSc ;   Li Ma   1, 2 , PhD ;   Liping Su   1, 2 , PhD

1 Department of Hematology, Shanxi Province Cancer Hospital/ Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences /Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi Province, China

2 Shanxi Provincial Key Laboratory of Lymphoma Precision Diagnosis and Treatment Research, Taiyuan, Shanxi Province, China

*these authors contributed equally

Corresponding Author:

  • Jin Zhao, MSc
  • Department of Hematology
  • Shanxi Province Cancer Hospital/ Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences /Cancer Hospital Affiliated to Shanxi Medical University
  • No.3, Zhigong New Street
  • Taiyuan, Shanxi Province 030013
  • China
  • Phone: 86 0351 4650984
  • Email: lemonjiner@163.com